Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma

Cancer Research

Volumn 61, Issue 11, 2001, Pages 4341-4344

  Monestiroli, S ^a   Mancuso, P ^a   Burlini, A ^a   Pruneri, G ^a   Dell'Agnola, C ^a   Gobbi, A ^a   Martinelli, G ^a   Bertolini, F ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; TUMOR MARKER; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COMPARTMENTALIZATION; CELL KINETICS; CELL VIABILITY; CONTROLLED STUDY; CORRELATION FUNCTION; ENDOTHELIUM CELL; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; IMMUNE DEFICIENCY; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME;

ANGIOGENESIS INHIBITORS; ANIMALS; BURKITT LYMPHOMA; CELL CYCLE; CELL SURVIVAL; COLLAGEN; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; ENDOSTATINS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035360833     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Angiogenesis in cancer, vascular, rheumatoid, and other diseases
2. Cancer: Looking outside the genome
3. Angiogenesis as a predictor of clinical outcome in cancer patients
4. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
5. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: Frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production
6. Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCD mouse model of human high-grade non-Hodgkin's lymphoma
7. Anti-angiogenic therapy of experimental cancer does not induce acquired drug resistance
8. The use of 7-amino actinomycin D in identifying apoptosis: Simplicity of use and broad spectrum of application compared with other techniques
9. CD105 antagonizes the inhibitory signaling of transforming growth factor β1 on human vascular endothelial cells
10. The biology of vascular endothelial growth factor
11. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer
12. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
13. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
14. Endothelial cells of tumor vessels: Abnormal but not absent
15. Can mosaic tumor vessels facilitate molecular diagnosis of cancer?
16. Angiogenesis assays: Problems and pitfalls
17. Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma
18. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: A single-institution study of 200 patients